Further functional studies showed that miR221/222 directly targeted and inhibited phosphate and tension homology (Pten) expression and promoted tumour progression, and METTL3 plays a cancerous role in BC by positively regulating pri-miR221/222 processes in an m6A-dependent way. Here, METTL3 is linked to breast cancer.